WZ3146Mutant EGFR inhibitor, potent and irreversible CAS# 1214265-56-1 |
- Dacomitinib (PF299804, PF299)
Catalog No.:BCC3683
CAS No.:1110813-31-4
- AP26113
Catalog No.:BCC1069
CAS No.:1197958-12-5
- PD153035 hydrochloride
Catalog No.:BCC3617
CAS No.:153436-54-5
- Compound 56
Catalog No.:BCC3615
CAS No.:171745-13-4
- Lapatinib
Catalog No.:BCC3633
CAS No.:231277-92-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1214265-56-1 | SDF | Download SDF |
PubChem ID | 44607360 | Appearance | Powder |
Formula | C24H25ClN6O2 | M.Wt | 464.95 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 150 mg/mL (322.62 mM; Need ultrasonic) | ||
Chemical Name | N-[3-[5-chloro-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | ||
SMILES | CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl | ||
Standard InChIKey | APHGZZPEOCCYNO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C24H25ClN6O2/c1-3-22(32)27-18-5-4-6-20(15-18)33-23-21(25)16-26-24(29-23)28-17-7-9-19(10-8-17)31-13-11-30(2)12-14-31/h3-10,15-16H,1,11-14H2,2H3,(H,27,32)(H,26,28,29) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | WZ3146 is a potent and irreversible inhibitor of mutant EGFR with IC50 values of both 2 nM for EGFR(L858R) and EGFR(E746_A750). | |||||
Targets | EGFR(L858R) | EGFR(E746_A750) | ||||
IC50 | 2 nM | 2 nM |
WZ3146 Dilution Calculator
WZ3146 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1508 mL | 10.7538 mL | 21.5077 mL | 43.0154 mL | 53.7692 mL |
5 mM | 0.4302 mL | 2.1508 mL | 4.3015 mL | 8.6031 mL | 10.7538 mL |
10 mM | 0.2151 mL | 1.0754 mL | 2.1508 mL | 4.3015 mL | 5.3769 mL |
50 mM | 0.043 mL | 0.2151 mL | 0.4302 mL | 0.8603 mL | 1.0754 mL |
100 mM | 0.0215 mL | 0.1075 mL | 0.2151 mL | 0.4302 mL | 0.5377 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
WZ3146 is a novel, irreversible inhibitor that specifically inhibits phosphorylation of EGFR(L858R0) and EGFR(E746_A750) with IC50 values of 2nM each.
WZ3146 has been reported to inhibit the phosphorylation of EGFR in the Non–Small-Cell Lung Cancer (NSCLC) cell lines [1]. WZ3146 shows to suppress the growth of EGFR T790M containing cell lines. Besides, Analysis of recombinant EGFR T790M kinase incubated with WZ3146 by electrospray mass spectrometry revealed stoichiometric addition of one inhibitor molecule to the protein. Analysis of a pepsin digest of the modified protein by tandem MS identified Cys 797 as the site of modification thus verifying covalent bond formation between WZ3146 and EGFR [2].
References:
[1] Thanyanan Reungwetwattana, Saravut J. Weroha, Julian R. Molina. Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC). Clinical Lung Cancer, Volume 13, Issue 4, July 2012, Pages 252-266
[2] Zhou W1, Ercan D, Chen L, Yun CH, Li D, Capelletti M, Cortot AB, Chirieac L, Iacob RE, Padera R, Engen JR, Wong KK, Eck MJ, Gray NS, Jänne PA. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature. 2009 Dec 24;462(7276):1070-4.
- POM 1
Catalog No.:BCC7454
CAS No.:12141-67-2
- N6-Benzyladenine
Catalog No.:BCC9076
CAS No.:1214-39-7
- Bernardioside A
Catalog No.:BCN7862
CAS No.:121368-52-3
- SR 33805 oxalate
Catalog No.:BCC7181
CAS No.:121346-33-6
- Fmoc-Glu-OH
Catalog No.:BCC3489
CAS No.:121343-82-6
- WZ4002
Catalog No.:BCC1074
CAS No.:1213269-23-8
- 1-Hydroxybisabola-2,10-dien-4-one
Catalog No.:BCN7297
CAS No.:1213251-45-6
- RWJ 21757
Catalog No.:BCC7460
CAS No.:121288-39-9
- Alendronate
Catalog No.:BCC4885
CAS No.:121268-17-5
- ICI 204,448 hydrochloride
Catalog No.:BCC6806
CAS No.:121264-04-8
- Calphostin C
Catalog No.:BCC7131
CAS No.:121263-19-2
- Secodihydro-hydramicromelin B
Catalog No.:BCN4783
CAS No.:1212148-58-7
- WZ8040
Catalog No.:BCC1075
CAS No.:1214265-57-2
- WZ4003
Catalog No.:BCC4363
CAS No.:1214265-58-3
- Ajugapantin A
Catalog No.:BCN3663
CAS No.:121449-67-0
- Daclatasvir (BMS-790052)
Catalog No.:BCC2533
CAS No.:1214735-16-6
- 5-Benzyloxyindole
Catalog No.:BCC8742
CAS No.:1215-59-4
- PF-04991532
Catalog No.:BCC8094
CAS No.:1215197-37-7
- Salvianolic acid B; Lithospermic acid B; Danfensuan B
Catalog No.:BCC8249
CAS No.:121521-90-2
- SR 58611A hydrochloride
Catalog No.:BCC7833
CAS No.:121524-09-2
- GR 144053 trihydrochloride
Catalog No.:BCC6998
CAS No.:1215333-48-4
- RG2833
Catalog No.:BCC1893
CAS No.:1215493-56-3
- CFM 1571 hydrochloride
Catalog No.:BCC5924
CAS No.:1215548-30-3
- SB 242084
Catalog No.:BCC5949
CAS No.:1215566-78-1